Zhang Qiang, Li Yuhuan, Chang Xiaozan
Department of Neurosurgery, The 961 Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, No. 71 Postal Road, Qiqihar 161000, Heilongjiang.
Department of Neurosurgery, Beijing Crops Hospital of Chinese People Armed Police Forces, Beijing.
Ann Indian Acad Neurol. 2023 Nov-Dec;26(6):966-974. doi: 10.4103/aian.aian_432_23. Epub 2023 Dec 20.
Traumatic brain injury (TBI) is a serious medical condition that often leads to significant morbidity and mortality. Decompressive craniectomy (DC) is now widely recognized as a primary or secondary treatment option for managing intracranial pressure (ICP) in patients with severe TBI. However, there is a lack of clarity in reviews regarding the impact of DC on TBI outcomes.
The aim of this study is to evaluate the effectiveness of DC in terms of overall mortality and long-term prognosis among patients with TBI.
We conducted a systematic search of four common databases to include all parallel-arm randomized controlled trials (RCTs). We selected studies that reported outcomes for TBI cases, with DC as a treatment option. The outcomes examined included reduction in mortality, ICP levels, and the proportion of patients with a Glasgow Outcome Scale score >4.
Our review finally included eight RCTs [ = 1458, with 749 and 709 patients in the DC and control groups, respectively]. The weighted mean difference for ICP was estimated at -4.01 (95% Confidence interval [CI]: -5.31--2.71), indicating a statistically significant reduction in ICP levels in the DC group compared to the control group. The pooled risk ratio was 0.67 (95% CI: 0.51-0.89), suggesting a statistically significant 31% decrease in mortality levels in the DC group. Subgroup and sensitivity analyzes were also conducted to address heterogeneity.
In conclusion, based on our meta-analysis, we find that DC can be considered a crucial surgical intervention for reducing mortality among patients with TBI when compared to control groups.
创伤性脑损伤(TBI)是一种严重的病症,常导致显著的发病率和死亡率。减压性颅骨切除术(DC)目前被广泛认为是治疗重度TBI患者颅内压(ICP)的主要或次要治疗选择。然而,关于DC对TBI预后影响的综述尚缺乏明确结论。
本研究旨在评估DC在TBI患者总体死亡率和长期预后方面的有效性。
我们对四个常见数据库进行了系统检索,纳入所有平行组随机对照试验(RCT)。我们选择报告TBI病例结局且将DC作为治疗选择的研究。所考察的结局包括死亡率降低、ICP水平以及格拉斯哥预后量表评分>4的患者比例。
我们的综述最终纳入八项RCT[ = 1458,DC组和对照组分别有749例和709例患者]。ICP的加权平均差估计为-4.01(95%置信区间[CI]:-5.31--2.71),表明DC组的ICP水平与对照组相比有统计学显著降低。合并风险比为0.67(95%CI:0.51 - 0.89),提示DC组死亡率水平有统计学显著降低31%。还进行了亚组分析和敏感性分析以解决异质性问题。
总之,基于我们的荟萃分析,我们发现与对照组相比,DC可被视为降低TBI患者死亡率的关键手术干预措施。